| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211845 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 27 Pages |
Abstract
Six-fraction SBRT for CLM is safe and may be associated with long-term cure. Local control was significantly associated with delivered dose and was lower than seen in other studies using a higher SBRT dose. Survival was associated with smaller tumor volume, absence of extrahepatic disease, performance status of 0 or 1, and local control of treated liver lesions.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Andrew MBChB, Anand MD, Ri Wang, Melania MSc, James MD, John MD, Jolie MSc, MD, Rebecca MSc, MBChB, Rob MSc, MD, Tim PhD, Laura A. MD,